CAS 1132709-15-9
:B-[(1R)-3-Methyl-1-[[(2R)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]boronic acid
Description:
B-[(1R)-3-Methyl-1-[[(2R)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]boronic acid is a complex organic compound characterized by its boronic acid functional group, which is known for its ability to form reversible covalent bonds with diols. This compound features a chiral center, indicated by the (1R) and (2R) stereochemistry, which contributes to its potential biological activity and specificity in interactions. The presence of a phenyl group and a pyrazinylcarbonyl moiety suggests that it may exhibit significant interactions with biological targets, possibly in medicinal chemistry applications. The boronic acid group is often utilized in drug design for its ability to modulate enzyme activity and participate in molecular recognition processes. Additionally, the compound's structure indicates potential for use in targeted therapies, particularly in the context of cancer treatment or other diseases where specific enzyme inhibition is desired. Overall, this compound exemplifies the intricate relationship between molecular structure and biological function in pharmaceutical chemistry.
Formula:C19H25BN4O4
InChI:InChI=1S/C19H25BN4O4/c1-13(2)10-17(20(27)28)24-18(25)15(11-14-6-4-3-5-7-14)23-19(26)16-12-21-8-9-22-16/h3-9,12-13,15,17,27-28H,10-11H2,1-2H3,(H,23,26)(H,24,25)/t15-,17+/m1/s1
InChI key:InChIKey=GXJABQQUPOEUTA-WBVHZDCISA-N
SMILES:[C@@H](CC1=CC=CC=C1)(C(N[C@@H](CC(C)C)B(O)O)=O)NC(=O)C=2C=NC=CN2
Synonyms:- B-[(1R)-3-Methyl-1-[[(2R)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]boronic acid
- Boronic acid, B-[(1R)-3-methyl-1-[[(2R)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]-
- Bortezomib impurity 1/(1R,2R)-Bortezomib
- Bortezomib 1R, 2R Isomer Q: What is the storage condition of
- Bortezomib USP RC A
- (1R,2R)-Bortezomib Impurity
- Bortezomib 1R, 2R Isomer Q: What are the applications of
- Bortezomib USP Related Compoud H
- Bortezomib Diastereomer (R,R)
- Bortizomib RR (Diastereomer)
- [(1R)-3-Methyl-1-[[(2R)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]boronic Acid
- ((R)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxaMido)propanaMido)butyl)boronic acid
- N-(2-Pyrazinecarbonyl)-D-phenylalanine-L-leucine boronic anhydride
- Bortezomib 1R, 2R Isomer
- Boron tezomio enantiomers (RR)
- Bortezomib 1R, 2R IsomerQ: What is
- [(1R)-3-Methyl-1-[[(2R)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]boronic acid
- Bortezomib Related Compound A/ Bortezomib Impurity D (Bortezomib R,R-Isomer Impurity)
- Bortezomib 1R, 2R Isomer Q: What is the CAS Number of
- (1R,2R)-BortezoMib
- See more synonyms
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 5 products.
((R)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid
CAS:Formula:C19H25BN4O4Purity:%Color and Shape:SolidMolecular weight:384.2372((R)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid
CAS:((R)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acidPurity:98%Molecular weight:384.25g/mol(1R,2R)-Bortezomib
CAS:Formula:C19H25BN4O4Color and Shape:White To Off-White SolidMolecular weight:384.24(1R,2R)-Bortezomib
CAS:<p>Impurity Bortezomib USP Related Compound A<br>Applications (1R,2R)-Bortezomib is a diastereomer of Bortezomib (B675700), the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-shaped multiprotein particle found in the nucleus and cytosol of all eukaryotic cells. Targets the ubiquitin-proteasome pathway<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Nawrocki, S.T., et al: Cancer Research, 65, 11510 (2005); Drahl C.: Chem. and Eng. News, 87, 41 (2009)<br></p>Formula:C19H25BN4O4Purity:>85%Color and Shape:NeatMolecular weight:384.24




